Cite
Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects
MLA
Guobin Ren, et al. “Development of Gliclazide Ionic Liquid and the Transdermal Patches: An Effective and Noninvasive Sustained Release Formulation to Achieve Hypoglycemic Effects.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, vol. 164, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6472c870b8203060cc997c3d3091e413&authtype=sso&custid=ns315887.
APA
Guobin Ren, Minghuang Hong, He-Mei Yin, Bi-Jian Zhou, Ming-Hui Qi, & Siyuan Liu. (2021). Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 164.
Chicago
Guobin Ren, Minghuang Hong, He-Mei Yin, Bi-Jian Zhou, Ming-Hui Qi, and Siyuan Liu. 2021. “Development of Gliclazide Ionic Liquid and the Transdermal Patches: An Effective and Noninvasive Sustained Release Formulation to Achieve Hypoglycemic Effects.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 164 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6472c870b8203060cc997c3d3091e413&authtype=sso&custid=ns315887.